Literature DB >> 15180669

A conditional Markov model for clustered progressive multistate processes under incomplete observation.

Richard J Cook1, Grace Y Yi, Ker-Ai Lee, Dafna D Gladman.   

Abstract

Clustered progressive chronic disease processes arise when interest lies in modeling damage in paired organ systems (e.g., kidneys, eyes), in diseases manifest in different organ systems, or in systemic conditions for which damage may occur in several locations of the body. Multistate Markov models have considerable appeal for modeling damage in such settings, particularly when patients are only under intermittent observation. Generalizations are necessary, however, to deal with the fact that processes within subjects may not be independent. We describe a conditional Markov model in which the clustering in processes within subjects is addressed by the use of multiplicative random effects for each transition intensity. The random effects for the different transition intensities may be correlated within subjects, but are assumed to be independent for different subjects. We apply the mixed Markov model to a motivating data set of patients with psoriatic arthritis, and characterize the progressive course of damage in joints of the hand. A generalization to accommodate a subpopulation of "stayers" and extensions which facilitate regression are indicated and illustrated.

Entities:  

Mesh:

Year:  2004        PMID: 15180669     DOI: 10.1111/j.0006-341X.2004.00188.x

Source DB:  PubMed          Journal:  Biometrics        ISSN: 0006-341X            Impact factor:   2.571


  12 in total

1.  Non-homogeneous Markov process models with informative observations with an application to Alzheimer's disease.

Authors:  Baojiang Chen; Xiao-Hua Zhou
Journal:  Biom J       Date:  2011-04-14       Impact factor: 2.207

2.  A Correlated Random Effects Model for Non-homogeneous Markov Processes with Nonignorable Missingness.

Authors:  Baojiang Chen; Xiao-Hua Zhou
Journal:  J Multivar Anal       Date:  2013-05       Impact factor: 1.473

3.  A Multistate Transition Model for Osteoarthritis Pain Change.

Authors:  Bin Zhang; Haiqun Lin; David J Hunter; Tuhina Neogi; Barton Wise; Ernest Choy; Jingbo Niu; Yuqing Zhang
Journal:  Commun Stat Theory Methods       Date:  2009-01-01       Impact factor: 0.893

4.  Estimating time-to-event from longitudinal ordinal data using random-effects Markov models: application to multiple sclerosis progression.

Authors:  Micha Mandel; Rebecca A Betensky
Journal:  Biostatistics       Date:  2008-04-18       Impact factor: 5.899

5.  Analysis of Smoking Cessation Patterns Using a Stochastic Mixed-Effects Model With a Latent Cured State.

Authors:  Sheng Luo; Ciprian M Crainiceanu; Thomas A Louis; Nilanjan Chatterjee
Journal:  J Am Stat Assoc       Date:  2008-09-01       Impact factor: 5.033

6.  A case-study in the clinical epidemiology of psoriatic arthritis: multistate models and causal arguments.

Authors:  Aidan G O'Keeffe; Brian D M Tom; Vernon T Farewell
Journal:  J R Stat Soc Ser C Appl Stat       Date:  2011-11       Impact factor: 1.864

7.  The versatility of multi-state models for the analysis of longitudinal data with unobservable features.

Authors:  Vernon T Farewell; Brian D M Tom
Journal:  Lifetime Data Anal       Date:  2012-12-06       Impact factor: 1.588

8.  Mixture distributions in multi-state modelling: some considerations in a study of psoriatic arthritis.

Authors:  Aidan G O'Keeffe; Brian D M Tom; Vernon T Farewell
Journal:  Stat Med       Date:  2012-07-26       Impact factor: 2.373

9.  Trivariate mover-stayer counting process models for investigating joint damage in psoriatic arthritis.

Authors:  Sean Yiu; Brian D M Tom; Vernon T Farewell
Journal:  Stat Med       Date:  2016-08-08       Impact factor: 2.373

10.  Clustered multistate models with observation level random effects, mover-stayer effects and dynamic covariates: modelling transition intensities and sojourn times in a study of psoriatic arthritis.

Authors:  Sean Yiu; Vernon T Farewell; Brian D M Tom
Journal:  J R Stat Soc Ser C Appl Stat       Date:  2017-07-25       Impact factor: 1.864

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.